drugset / Trial / NCT00537329

Anidulafungin In Treatment Of Candidemia In Asian Subjects

NCT00537329

Phase 3 Completed 43 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether or not the Investigational Study Drug anidulafungin is safe and effective in the treatment of a fungal infection, candidemia, in Asian subjects.

Timeline

Start
2008-01
Primary completion
2009-03
Completion
2009-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Anidulafungin Other / unclassified 100 mg Intravenous

Indications